Cargando…
Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
Background: The t:slim X2™ insulin pump with Control-IQ™ technology, an advanced hybrid closed-loop system, became available in the United States in early 2020. Real-world outcomes with use of this system have not yet been comprehensively reported. Methods: Individuals with type 1 diabetes (T1D) (≥1...
Autores principales: | Pinsker, Jordan E., Müller, Lars, Constantin, Alexandra, Leas, Scott, Manning, Michelle, McElwee Malloy, Molly, Singh, Harsimran, Habif, Steph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868573/ https://www.ncbi.nlm.nih.gov/pubmed/32846114 http://dx.doi.org/10.1089/dia.2020.0388 |
Ejemplares similares
-
Virtual Pump Trainings for the t:slim X2 Insulin Pump With Control-IQ Advanced Hybrid Closed-Loop Technology: Real World Patient Experience
por: Singh, Harsimran, et al.
Publicado: (2021) -
SAT-LB113 Psychosocial Benefits of Using Basal-IQ® Predictive Low Glucose Suspend Technology in a Real-World Setting: Results From Pediatric Patients With Type 1 Diabetes
por: Singh, Harsimran, et al.
Publicado: (2020) -
Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort
por: Müller, Lars, et al.
Publicado: (2019) -
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
por: Breton, Marc D., et al.
Publicado: (2021) -
Addressing the age-old question of old age
por: McElwee, Joshua J
Publicado: (2004)